Exclusion criteria
liver, kidney, heart, diabetes, AUB, breast cancers, hyperplasia
ABNORMAL UTERINE BLEEDING, BREAST CANCER, HYPERPLASIA, LEIOMYOMA, THROMBOEMBOLIC DISEASE
However, those with localized endometrial lesions like leiomyoma or atypical or complicated hyperplasia who have had hormone treatment within the last six months are at higher risk and other causes of abnormal uterine bleeding (AUB) like adnexal swellings and genital and breast cancers were excluded. Also, patients with liver, kidney, heart, diabetes, thromboembolic diseases or steroid therapy were ineligible.Outcomes of therapeutic treatment of EH for six months